Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stack Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Stack Diagnostics

Stack Diagnostics

Closed

Stack Diagnostics: Innovating healthcare with genomics and AI for affordable, precise treatments.

HQ
Newark, DE, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Stack Diagnostics is a healthcare innovator focused on enhancing the application of genomics and AI in diagnosing and treating patients. Founded in 2018 and headquartered in Delaware, USA, the company provides genetic testing services both in clinical settings and directly to consumers at affordable prices. Their mission is to make precise, personalized healthcare accessible through advanced technology.

Since its inception, Stack Diagnostics has made significant strides in integrating cutting-edge genomics and AI into healthcare, improving diagnostic accuracy and treatment outcomes. The company's commitment to affordability and precision has positioned it as a key player in the healthcare innovation space, impacting numerous lives through its advanced genetic testing services.

Stack Diagnostics - Similar Companies

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Juno Diagnostics logo

Juno Diagnostics

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Invitae logo

Invitae

invitae.com

Geneicd logo

Geneicd

Sivotec Bioinformatics logo

Sivotec Bioinformatics

Empowered Diagnostics logo

Empowered Diagnostics

Neodiagnostix logo

Neodiagnostix

neodiagnostix.com

SensOmics logo

SensOmics

Population Diagnostics logo

Population Diagnostics

ThinkGenetic logo

ThinkGenetic

thinkgenetic.com

Accessible Diagnostics logo

Accessible Diagnostics

Nest Genomics logo

Nest Genomics

nestgenomics.com

Fulgent Diagnostics logo

Fulgent Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Stack Diagnostics - Quick Facts

Who are Stack Diagnostics' competitors?

Companies similar to Stack Diagnostics include GeneDx Holdings, Juno Diagnostics, Predictive Health Diagnostics Company and Invitae.

When was Stack Diagnostics founded?

Stack Diagnostics was founded in 2018.

Where is Stack Diagnostics' headquarters located?

Stack Diagnostics' headquarters is located in Newark, DE, US.

When was Stack Diagnostics' last funding round?

Stack Diagnostics' most recent funding round was for $18.7M (USD) in April 2020.

How much has Stack Diagnostics raised to-date?

As of Apr 1, 2020, Stack Diagnostics has raised a total of $18.8M (USD).

Stack Diagnostics - Classification

Technology
  • AI
  • Genomics
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Genetic Testing
Tags
  • Biotech
  • Data
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8060Hospitals